We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA, AdvaMed Say FDA’s Intended Use Final Rule Could Chill Speech
PhRMA, AdvaMed Say FDA’s Intended Use Final Rule Could Chill Speech
PhRMA and AdvaMed expressed “grave concerns” about the FDA’s final rule clarifying when tobacco products are regulated as medical products, saying that the rule’s altered “intended use” definition is overbroad in its restriction of communications.